Page last updated: 2024-10-19

orotic acid and 2019 Novel Coronavirus Disease

orotic acid has been researched along with 2019 Novel Coronavirus Disease in 2 studies

Orotic Acid: An intermediate product in PYRIMIDINE synthesis which plays a role in chemical conversions between DIHYDROFOLATE and TETRAHYDROFOLATE.
orotic acid : A pyrimidinemonocarboxylic acid that is uracil bearing a carboxy substituent at position C-6.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Clyde, A1
Galanie, S1
Kneller, DW1
Ma, H1
Babuji, Y1
Blaiszik, B1
Brace, A1
Brettin, T1
Chard, K1
Chard, R1
Coates, L1
Foster, I1
Hauner, D1
Kertesz, V1
Kumar, N1
Lee, H1
Li, Z1
Merzky, A1
Schmidt, JG1
Tan, L1
Titov, M1
Trifan, A1
Turilli, M1
Van Dam, H1
Chennubhotla, SC1
Jha, S1
Kovalevsky, A1
Ramanathan, A1
Head, MS1
Stevens, R1
Gao, S1
Sylvester, K1
Song, L1
Claff, T1
Jing, L1
Woodson, M1
Weiße, RH1
Cheng, Y1
Schäkel, L1
Petry, M1
Gütschow, M1
Schiedel, AC1
Sträter, N1
Kang, D1
Xu, S1
Toth, K1
Tavis, J1
Tollefson, AE1
Müller, CE1
Liu, X1
Zhan, P1

Other Studies

2 other studies available for orotic acid and 2019 Novel Coronavirus Disease

ArticleYear
High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor.
    Journal of chemical information and modeling, 2022, 01-10, Volume: 62, Issue:1

    Topics: Antiviral Agents; Coronavirus 3C Proteases; COVID-19; Humans; Molecular Docking Simulation; Molecula

2022
Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity.
    Journal of medicinal chemistry, 2022, 10-13, Volume: 65, Issue:19

    Topics: Antiviral Agents; Caspase 3; Cathepsins; Coronavirus 3C Proteases; COVID-19; Cysteine Endopeptidases

2022